Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Hepatitis B
Related studies linked through entity extraction aliases.
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE4
The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
- Status
- COMPLETED
- Phase
- N/A
Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients
- Status
- COMPLETED
- Phase
- PHASE1
Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y
- Status
- COMPLETED
- Phase
- PHASE2
Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders
- Status
- COMPLETED
- Phase
- PHASE3
Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules
- Status
- COMPLETED
- Phase
- PHASE2